Bessemer Group Inc Sarepta Therapeutics, Inc. Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 62 shares of SRPT stock, worth $7,693. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$7,693

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$124.33 - $156.75 $7,708 - $9,718	62 New	62 $8,000
Q2 2022 Aug 10, 2022	SELL	$62.69 - $88.44 $5,516 - $7,782	-88 Reduced 88.89%	11 $1,000
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $329 - $462	-5 Reduced 4.81%	99 $9,000
Q1 2021 May 13, 2021	BUY	$72.25 - $168.95 $7,008 - $16,388	97 Added 1385.71%	104 $7,000
Q4 2020 Feb 09, 2021	SELL	$125.56 - $178.74 $4,269 - $6,077	-34 Reduced 82.93%	7 $2,000
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $30.6 Million - $41.5 Million	-241,062 Reduced 99.98%	41 $6,000
Q2 2020 Aug 05, 2020	BUY	$93.0 - $171.7 $651 - $1,201	7 Added 0.0%	241,103 $38.7 Million
Q4 2019 Feb 04, 2020	BUY	$76.53 - $135.58 $18.5 Million - $32.7 Million	241,096 New	241,096 $31.1 Million
Q3 2019 Nov 07, 2019	SELL	$72.81 - $156.91 $15.9 Million - $34.3 Million	-218,644 Closed	0 $0
Q2 2019 Jul 19, 2019	BUY	$112.21 - $151.95 $24.5 Million - $33.2 Million	218,587 Added 383485.97%	218,644 $33.2 Million
Q1 2019 May 13, 2019	SELL	$106.67 - $151.68 $171,632 - $244,053	-1,609 Reduced 96.58%	57 $7,000
Q4 2018 Feb 12, 2019	BUY	$97.32 - $148.76 $159,896 - $244,412	1,643 Added 7143.48%	1,666 $183,000
Q3 2018 Nov 06, 2018	BUY	$115.31 - $161.51 $2,652 - $3,714	23 New	23 $4,000
Q1 2018 May 10, 2018	SELL	$54.02 - $82.27 $54,020 - $82,270	-1,000 Closed	0 $0
Q4 2017 Jan 30, 2018	BUY	$47.64 - $56.75 $47,640 - $56,750	1,000	1,000 $56,000

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.28 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.11 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$777 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$541 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$530 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account